Judith Diane Schaechter, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyramidal Tracts | 4 | 2015 | 257 | 1.440 |
Why?
|
| Stroke | 13 | 2022 | 9963 | 0.800 |
Why?
|
| Somatosensory Cortex | 3 | 2011 | 527 | 0.740 |
Why?
|
| Movement | 4 | 2014 | 1470 | 0.690 |
Why?
|
| Motor Skills | 4 | 2011 | 518 | 0.660 |
Why?
|
| Functional Laterality | 6 | 2011 | 2290 | 0.530 |
Why?
|
| Hemiplegia | 2 | 2007 | 135 | 0.520 |
Why?
|
| Paresis | 4 | 2011 | 179 | 0.510 |
Why?
|
| Upper Extremity | 3 | 2015 | 648 | 0.470 |
Why?
|
| Physical Therapy Modalities | 2 | 2011 | 547 | 0.470 |
Why?
|
| Motor Cortex | 5 | 2007 | 984 | 0.390 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2015 | 2304 | 0.350 |
Why?
|
| Recovery of Function | 6 | 2011 | 2924 | 0.350 |
Why?
|
| Restraint, Physical | 1 | 2009 | 193 | 0.320 |
Why?
|
| Neuronal Plasticity | 3 | 2006 | 1418 | 0.320 |
Why?
|
| Motor Activity | 6 | 2015 | 2714 | 0.280 |
Why?
|
| Cerebrum | 1 | 2007 | 137 | 0.270 |
Why?
|
| Fingers | 2 | 2006 | 514 | 0.250 |
Why?
|
| Brain | 5 | 2022 | 26343 | 0.250 |
Why?
|
| Psychomotor Performance | 3 | 2007 | 1895 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2022 | 35342 | 0.230 |
Why?
|
| Robotics | 1 | 2011 | 892 | 0.220 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3328 | 0.220 |
Why?
|
| Hand Strength | 3 | 2014 | 444 | 0.220 |
Why?
|
| Acupuncture Therapy | 1 | 2007 | 464 | 0.220 |
Why?
|
| Serotonin | 3 | 1990 | 1024 | 0.190 |
Why?
|
| Hypothalamus | 4 | 1990 | 1063 | 0.190 |
Why?
|
| Tryptophan | 3 | 1990 | 478 | 0.180 |
Why?
|
| Chronic Disease | 7 | 2011 | 9144 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2011 | 8925 | 0.160 |
Why?
|
| Anisotropy | 2 | 2014 | 1265 | 0.160 |
Why?
|
| Frontal Lobe | 1 | 2022 | 1407 | 0.130 |
Why?
|
| Movement Disorders | 2 | 2015 | 444 | 0.130 |
Why?
|
| Fatigue | 1 | 2022 | 1526 | 0.130 |
Why?
|
| Synaptosomes | 1 | 1993 | 115 | 0.120 |
Why?
|
| Motion Sickness | 1 | 2013 | 35 | 0.110 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 434 | 0.100 |
Why?
|
| Aged | 17 | 2015 | 162944 | 0.100 |
Why?
|
| Brain Mapping | 5 | 2009 | 6669 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2011 | 8297 | 0.090 |
Why?
|
| Nausea | 1 | 2013 | 665 | 0.090 |
Why?
|
| Middle Aged | 17 | 2015 | 213127 | 0.090 |
Why?
|
| Adult | 17 | 2014 | 213712 | 0.090 |
Why?
|
| Fenfluramine | 1 | 1989 | 60 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1227 | 0.080 |
Why?
|
| Phenylenediamines | 2 | 1985 | 90 | 0.080 |
Why?
|
| Oxygen | 2 | 2011 | 4169 | 0.070 |
Why?
|
| Female | 19 | 2015 | 379592 | 0.070 |
Why?
|
| Male | 19 | 2015 | 349538 | 0.070 |
Why?
|
| Hydroxyindoleacetic Acid | 3 | 1990 | 90 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2006 | 6365 | 0.070 |
Why?
|
| Humans | 24 | 2022 | 742088 | 0.070 |
Why?
|
| Acupuncture | 1 | 2005 | 90 | 0.070 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1985 | 113 | 0.060 |
Why?
|
| Acute Disease | 1 | 2015 | 7141 | 0.060 |
Why?
|
| Nerve Degeneration | 3 | 1985 | 748 | 0.060 |
Why?
|
| Ophthalmic Artery | 1 | 1984 | 60 | 0.060 |
Why?
|
| Rats, Inbred Strains | 3 | 1990 | 2191 | 0.060 |
Why?
|
| Prognosis | 2 | 2015 | 29010 | 0.060 |
Why?
|
| Hand | 2 | 2007 | 882 | 0.060 |
Why?
|
| Echo-Planar Imaging | 1 | 2007 | 659 | 0.060 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2002 | 32 | 0.060 |
Why?
|
| Young Adult | 3 | 2015 | 56350 | 0.060 |
Why?
|
| Rehabilitation | 1 | 2004 | 134 | 0.060 |
Why?
|
| Optic Neuritis | 1 | 1984 | 166 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 1525 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 3769 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39004 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2013 | 2971 | 0.050 |
Why?
|
| Visual Pathways | 2 | 1985 | 565 | 0.050 |
Why?
|
| Aneurysm | 1 | 1984 | 339 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 2 | 1998 | 1499 | 0.050 |
Why?
|
| Reaction Time | 1 | 2007 | 2092 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 1993 | 4465 | 0.050 |
Why?
|
| Electromyography | 2 | 2002 | 1391 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2001 | 152 | 0.050 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2009 | 1431 | 0.040 |
Why?
|
| Kinetics | 3 | 1993 | 6474 | 0.040 |
Why?
|
| Nerve Net | 1 | 2011 | 2174 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15530 | 0.040 |
Why?
|
| Retina | 2 | 1985 | 2611 | 0.040 |
Why?
|
| Artifacts | 1 | 2006 | 1903 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2011 | 57683 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4029 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2007 | 12017 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2006 | 4197 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3507 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 1990 | 1770 | 0.030 |
Why?
|
| Rats | 4 | 1993 | 24265 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1993 | 104 | 0.030 |
Why?
|
| Nerve Endings | 1 | 1993 | 109 | 0.030 |
Why?
|
| GAP-43 Protein | 1 | 1993 | 152 | 0.030 |
Why?
|
| Optic Nerve | 3 | 1985 | 548 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1993 | 252 | 0.030 |
Why?
|
| Autoradiography | 1 | 1993 | 749 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1997 | 719 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 2255 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1801 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 5705 | 0.020 |
Why?
|
| Biological Availability | 1 | 1990 | 396 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 40054 | 0.020 |
Why?
|
| Leucine | 1 | 1990 | 560 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 1989 | 258 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2006 | 21719 | 0.020 |
Why?
|
| Calcium | 2 | 1993 | 5753 | 0.020 |
Why?
|
| Optic Chiasm | 2 | 1985 | 87 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1993 | 3701 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1990 | 1135 | 0.020 |
Why?
|
| Fluoxetine | 1 | 1990 | 749 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1993 | 5180 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2011 | 62966 | 0.020 |
Why?
|
| Muscle Spasticity | 1 | 2005 | 154 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1993 | 2440 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1985 | 302 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1993 | 3744 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1984 | 472 | 0.010 |
Why?
|
| Geniculate Bodies | 1 | 1984 | 163 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8300 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1993 | 8436 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1985 | 652 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2736 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1985 | 1099 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2005 | 1577 | 0.010 |
Why?
|
| Animals | 4 | 1993 | 168561 | 0.010 |
Why?
|
| Light | 1 | 1984 | 1374 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1989 | 10943 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 2414 | 0.010 |
Why?
|
| Transducers | 1 | 1997 | 252 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 5948 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1676 | 0.010 |
Why?
|
| Nervous System | 1 | 1997 | 553 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1984 | 2623 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12242 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4982 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1984 | 12958 | 0.010 |
Why?
|
| Equipment Design | 1 | 1997 | 3582 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1997 | 1617 | 0.000 |
Why?
|
| Quality of Life | 1 | 2005 | 12730 | 0.000 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1984 | 147 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2005 | 53187 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 20928 | 0.000 |
Why?
|
| Retinal Ganglion Cells | 1 | 1984 | 771 | 0.000 |
Why?
|
| Axons | 1 | 1984 | 1681 | 0.000 |
Why?
|